TNF and infection: Studies indicate that the relative risk of severe infections in elderly patients treated with TNF-α inhibitors is 1.59 (95% CI: 1.45–1.76), with heightened risk in patients with underlying cardiovascular disease or a history of malignancy (Pavlov-Dolijanovic et al., 2023).